CSSi, a patient recruitment solutions provider, has formed a LifeSciences division. This entity was created to complement CSSi’s service offerings by providing guidance and support for all phases of the product lifecycle, from product concept and early planning to post-approval compliance and surveillance.

The LifeSciences team is being led by James Sergi, who held various positions in academic nursing and cancer research before co-founding and working as CEO of a healthcare services and drug development company. His academic and medical experience includes director and administrator for the Department of Experimental Therapeutics at the Cleveland Clinic Cancer Center, associate professor of Medical-Surgical Nursing at the Case Western Reserve University Frances Payne Bolton School of Nursing and research manager of Hematology and Medical Oncology at the Cleveland Veterans Administration Medical Center Research Division.

"The regulatory industry is constantly changing and evolving, which presents continued challenges to pharmaceutical companies who are tasked with bringing new drugs to market quickly while maintaining cost efficiency," said Chris Trizna, president of CSSi. "CSSi is thrilled to bring Jim Sergi on board as president to lead this new division. His extensive experience in the regulatory industry will allow us to increase our global operation capabilities as pharmaceutical companies are relying more on outsourcing regulatory needs to market their new medicines."